Copy
View this email in your browser
June 19/23
🍁 Health Canada New Updated Links Welireg /Belzutifan*

*Drug and Health Product Portal – “Information on drugs and health products authorized by Health Canada.” Regulatory Decision Summary for Welireg

The pages/links have been moved for the links in the blog "Summary Welireg /Belzutifan Health Canada,” April 30/23
 
Summaries include reviews of: “clinical pharmacology, efficacy, and safety and non-clinical components of the submission… The Canadian regulatory decision on the Welireg NDS was made independently based on a critical assessment of the data package submitted to Health Canada.”

 
Donate
Help us to fill a gap in Canada.
We have moderate expenses to operate a peer support network specifically for VHL patients and their families in Canada.


VHL Canada
Registered Charity BN: 800804676RR0001

Our temporary mailing address is:
VHL Canada
C/O: H. Seo
618 Gladstone Avenue
Toronto ON, M6J 3H4

 
Want to change how you receive these emails?
You can
update your preferences or unsubscribe from this list.

 






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
VHL Canada · 2938 Dundas Street West, PO Box 70510 · Toronto, On M6P 4E7 · Canada

Email Marketing Powered by Mailchimp